Liminatus Pharma, LLC (LIMN)

Market Cap	56.88M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	7.07M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	96,554
Open	8.62
Previous Close	10.07
Day's Range	6.28 - 8.62
52-Week Range	6.01 - 16.44
Beta	0.25
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About LIMN

Liminatus Pharma, LLC operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company was incorporated in 2018 and is based in LA Palma, California. As on April 30, 2025, Liminatus Pharma, LLC went public through a reverse merger with Iris Acquisition Corp.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: LIMN